Drug Trial Radar · NCT00646945
Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology
Last checked: Nov 20, 2026Latest source record: Sep 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
204
Actual
Start
Sep 2007
Primary completion
Oct 2008
Study completion Oct 2008
Sponsor
- Lead sponsor
- Air Liquide Santé InternationalIndustry
- Sponsor type
- Industry
- First posted
- Mar 31, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In the oncology practice, The National Union of the Centres of Fight Against the Cancer recently published the Standards, Options and Recommendations for the coverage of the pains provoked during the invasive gestures of a short duration realized at patients affected by cancer. These support the use of the Kalinox ® 170 bar as therapeutic alternative for the preparation of the painful procedures of a short duration such as spinal taps or osseous at the adult.The objective of this study thus is to clarify the appropriate efficiency and the tolerance of the equimolar mixture protoxide of nitrogen / oxygen during invasive procedures realized in adult oncology with regard to the analgesic reference methods and to the effect placebo leads by the accompaniment of the patient during the procedure.
Conditions
- Cancer
- Pain
Interventions
50% Oxygen/50% Nitrous oxide premix (Kalinox 170 bar)Drug
gas flow between 4 to 15 L/min
50% Oxygen/50% Nitrogen premixDrug
gas flow between 4 to 15 L/min
Primary outcomes
What the sponsor says the trial is designed to measure.
- pain measurement with visual analogue scaleTime frame: EVA
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Centre Alexis Vautrin
Vandœuvre-lès-Nancy, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.